30 July 2021Ardelyx (ARDX.Q) Swings and Misses, Receives Complete Response Letter from…Kieran Robertson ARDX.Q Ardelyx (ARDX.Q) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s New Drug Application (NDA) for…